We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UUUU icon
3851
CALL
Energy Fuels
UUUU
$3.7B
$3.98K ﹤0.01%
+39,800
New +$264K
MTEM
3852
DELISTED
Molecular Templates, Inc.
MTEM
$3.79K ﹤0.01%
770
BP icon
3853
CALL
BP
BP
$111B
$3.76K ﹤0.01%
93,900
+5,500
+6% +$183K
OGEN icon
3854
Oragenics
OGEN
$2.48M
$3.56K ﹤0.01%
+19
New +$6.71K
FXI icon
3855
CALL
iShares China Large-Cap ETF
FXI
$4.25B
$2.75K ﹤0.01%
18,300
-1,000
-5% -$25.9K
MCHP icon
3856
CALL
Microchip Technology
MCHP
$44B
$2.64K ﹤0.01%
13,200
TGB
3857
CALL
Trekor Metals
TGB
$3.23B
$2.33K ﹤0.01%
46,700
ALK icon
3858
CALL
Alaska Air
ALK
$5.4B
$2.27K ﹤0.01%
45,300
+4,000
+10% +$176K
MMM icon
3859
CALL
3M
MMM
$94.4B
$2.23K ﹤0.01%
22,246
-23,561
-51% -$2.4M
SIEN
3860
DELISTED
Sientra, Inc.
SIEN
$2.12K ﹤0.01%
1,045
CALY
3861
CALL
Callaway Golf Company
CALY
$3.01B
$2.1K ﹤0.01%
+14,000
New +$276K
ARVL
3862
DELISTED
Arrival Ordinary Shares
ARVL
$2.05K ﹤0.01%
257
-20
-7% -$476
AMRS
3863
CALL
DELISTED
Amyris Inc.
AMRS
$1.92K ﹤0.01%
38,400
-15,600
-29% -$34.8K
TSN icon
3864
CALL
Tyson Foods
TSN
$19.9B
$1.84K ﹤0.01%
36,800
-15,000
-29% -$976K
WFC icon
3865
CALL
Wells Fargo
WFC
$264B
$1.72K ﹤0.01%
85,800
+1,300
+2% +$57.5K
PLAY icon
3866
CALL
Dave & Buster's
PLAY
$349M
$1.22K ﹤0.01%
24,300
-200
-0.8% -$7.23K
RITM icon
3867
CALL
Rithm Capital
RITM
$5.72B
$1.05K ﹤0.01%
+21,000
New +$175K
F icon
3868
CALL
Ford
F
$55.7B
$1.04K ﹤0.01%
54,800
-57,800
-51% -$743K
CEQP
3869
CALL
DELISTED
Crestwood Equity Partners LP
CEQP
$940 ﹤0.01%
18,800
STEM icon
3870
CALL
Stem
STEM
$52.8M
$870 ﹤0.01%
870
-50
-5% -$12K
NDAQ icon
3871
CALL
Nasdaq
NDAQ
$53.1B
$600 ﹤0.01%
12,000
-18,000
-60% -$1.12M
TTOO
3872
CALL
DELISTED
T2 Biosystems, Inc
TTOO
$570 ﹤0.01%
114
+112
+5,600% +$23K
MRO
3873
CALL
DELISTED
Marathon Oil Corporation
MRO
$525 ﹤0.01%
+17,500
New +$508K
BODY.WS
3874
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
$465 ﹤0.01%
11,199
KGC icon
3875
CALL
Kinross Gold
KGC
$32.3B
$301 ﹤0.01%
30,100

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.